Arlene Martinez-Rivera

Featured in: Favicon

science.org Favicon

Articles

Elevating levels of the endocannabinoid 2-arachidonoylglycerol blunts opioid reward but not analgesia

Nov 29, 2024 | science.org | Young-Cheul Shin |Yang Wu |Chaojiao Sun |Arlene Martinez-Rivera

AbstractConverging findings have established that the endocannabinoid (eCB) system serves as a possible target for the development of new treatments as a complement to opioid-based treatments.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →